Literature DB >> 11263551

Calcineurin-inhibitor induced pain syndrome (CIPS): a severe disabling complication after organ transplantation.

W H Grotz1, M K Breitenfeldt, S W Braune, K H Allmann, T M Krause, J A Rump, P J Schollmeyer.   

Abstract

Bone pain after transplantation is a frequent complication that can be caused by several diseases. Treatment strategies depend on the correct diagnosis of the pain. Nine patients with severe pain in their feet, which was registered after transplantation, were investigated. Bone scans showed an increased tracer uptake of the foot bones. Magnetic resonance imaging demonstrated bone marrow oedema in the painful bones. Pain was not explained by other diseases causing foot pain, like reflex sympathetic dystrophy, polyneuropathy, Morton's neuralgia, gout, osteoporosis, avascular necrosis, intermittent claudication, orthopaedic foot deformities, stress fractures, and hyperparathyroidism. The reduction of cyclosporine- or tacrolimus trough levels and the administration of calcium channel blockers led to relief of pain. The Calcineurin-inhibitor Induced Pain Syndrome (CIPS) is a rare but severe side effect of cyclosporine or tacrolimus and is accurately diagnosed by its typical presentation, magnetic resonance imaging and bone scans. Incorrect diagnosis of the syndrome will lead to a significant reduction of life quality in patients suffering from CIPS.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11263551     DOI: 10.1007/s001470000285

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  29 in total

1.  Calcineurin inhibitor-induced irreversible neuropathic pain after allogeneic hematopoietic stem cell transplantation.

Authors:  Nobuharu Fujii; Kazuma Ikeda; Motoko Koyama; Kazutoshi Aoyama; Taro Masunari; Eisei Kondo; Takashi Matsuzaki; Satoshi Mizobuchi; Akio Hiraki; Takanori Teshima; Katsuji Shinagawa; Fumihiko Ishimaru; Mitsune Tanimoto
Journal:  Int J Hematol       Date:  2006-06       Impact factor: 2.490

2.  Incapacitating lower limb pain syndrome in cord blood stem cell transplant recipients with calcineurin inhibitor.

Authors:  Aiko Kida; Kazuteru Ohashi; Takeshi Kobayashii; Miwa Sakai; Takuya Yamashita; Hideki Akiyama; Shuji Kishida; Hisashi Sakamaki
Journal:  Pathol Oncol Res       Date:  2004-12-27       Impact factor: 3.201

Review 3.  Metabolic bone diseases in kidney transplant recipients.

Authors:  Rubin Zhang; Kanwaljit K Chouhan
Journal:  World J Nephrol       Date:  2012-10-06

Review 4.  The neurology of solid organ transplantation.

Authors:  J David Avila; Saša Živković
Journal:  Curr Neurol Neurosci Rep       Date:  2015-07       Impact factor: 5.081

5.  A case report of disabling bone pain after long-term kidney transplantation.

Authors:  T M M Myint; M Vucak-Dzumhur; P R Ebeling; G J Elder
Journal:  Osteoporos Int       Date:  2013-06-26       Impact factor: 4.507

6.  Poor sleep in organ transplant recipients: self-reports and actigraphy.

Authors:  M Reilly-Spong; T Park; C R Gross
Journal:  Clin Transplant       Date:  2013-10-01       Impact factor: 2.863

7.  Ion channels and pain: important steps towards validating a new therapeutic target for neuropathic pain.

Authors:  James S Trimmer
Journal:  Exp Neurol       Date:  2014-02-05       Impact factor: 5.330

Review 8.  Bone and mineral disorders after kidney transplantation: therapeutic strategies.

Authors:  Miklos Z Molnar; Mohamed S Naser; Connie M Rhee; Kamyar Kalantar-Zadeh; Suphamai Bunnapradist
Journal:  Transplant Rev (Orlando)       Date:  2013-12-12       Impact factor: 3.943

9.  Case report: imaging features in a renal transplant patient with calcineurin inhibitor-induced pain syndrome (CIPS).

Authors:  Russell W Chapin; Elizabeth Chua; Jennifer Simmons; Martin Bunke
Journal:  Skeletal Radiol       Date:  2013-04-25       Impact factor: 2.199

10.  Familial hemiplegic migraine Ca(v)2.1 channel mutation R192Q enhances ATP-gated P2X3 receptor activity of mouse sensory ganglion neurons mediating trigeminal pain.

Authors:  Asha Nair; Manuela Simonetti; Nicol Birsa; Michel D Ferrari; Arn M J M van den Maagdenberg; Rashid Giniatullin; Andrea Nistri; Elsa Fabbretti
Journal:  Mol Pain       Date:  2010-08-24       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.